21 Small Cap Stocks Just Made New 52-Week Highs
As of Wednesday, November 18, there are 21 Small Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. Small Cap here means a market value between $2 billion and $10 billion, the upper figure excluded.
TG Therapeutics (TGTX), with a market value of about $9.3 billion, is the largest company on the list; its stock is up 21.3% over the past month and up 115.4% over the past year. By sector, Health Care leads the list with 9 of the 21 names. For context, the S&P 500 is down 5.0% over the past month, including dividends.

The Ten Largest At New Highs
The table below shows the 10 largest of the 21 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D Return |
1W Return |
1M Return |
1Y Return |
|---|---|---|---|---|---|
| TGTX | $9.3 Bil | 5.4% | 0.5% | 21.3% | 115.4% |
| RYTM | $8.2 Bil | 2.1% | 6.1% | 32.0% | 18.2% |
| AMRX | $7.3 Bil | 3.6% | 0.8% | 10.3% | 88.9% |
| TFX | $6.9 Bil | 3.9% | 6.3% | 26.7% | 61.3% |
| RLI | $6.5 Bil | 1.0% | 3.9% | 13.8% | 22.7% |
| TXNM | $6.2 Bil | 0.1% | 0.3% | 1.6% | 5.0% |
| VNT | $5.9 Bil | 1.8% | 0.4% | 29.3% | 27.0% |
| BILL | $5.7 Bil | 1.7% | 21.3% | 34.5% | 33.0% |
| CAKE | $5.6 Bil | 7.2% | 9.5% | 3.4% | 174.8% |
| CHH | $5.6 Bil | 3.5% | 3.7% | 9.7% | 36.7% |
Strong Prices, But How Strong Are The Businesses?
TG Therapeutics (TGTX) trades at 87.8 times trailing earnings, grew revenue 68.8% over the last twelve months and earned an operating margin of 21.5%.
Rhythm Pharmaceuticals (RYTM) grew revenue 61.0% over the last twelve months and posted an operating margin of -66.7%.
Across the list, one-month moves range from +1.3% for Organon (OGN) to +74.0% for Surgery Partners (SGRY).
The median stock on the list is up 49.8% over the past year.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Admire the list; own the system.